FDA 483 - Dr Reddy's Laboratories Limited - December 08, 2023

An FDA inspection of Dr Reddy's Laboratories Limited in Bachupally, India, revealed significant deficiencies in laboratory record-keeping, data integrity, and quality control procedures for complex analytical testing. The firm also failed to ensure employees received required training in GMP activities. These issues indicate a concerning lack of robust quality systems for drug product testing and data management.